Address: Ataköy 7-8-9-10. Kısım Mah. Çobançeşme E-5 Yan Yol Cad. B Apt. No:20 2/165 Bakırköy - İstanbul
  • Call us
    +90 212 212 03 52
  • Working hours
    Mon - Sat 08:00 - 20:00
  • E-Mail
    info@tbyholding.com
huge deal in the pharmaceutical sector from Turkey and Bosnia-Herzegovina

huge deal in the pharmaceutical sector from Turkey and Bosnia-Herzegovina

huge deal in the pharmaceutical sector from Turkey and Bosnia-Herzegovina
Mas İlaç Yatırım A.Ş. and the pharmaceutical manufacturer Zada ​​Pharmaceuticals from Bosnia and Herzegovina cooperated.

Mas İlaç Yatırım A.Ş. and the pharmaceutical manufacturer Zada ​​Pharmaceuticals from Bosnia and Herzegovina cooperated.

An agreement was signed between Mas İlaç Yatırım A.Ş, one of the Spektral Holding affiliates and pharmaceutical investment companies with the most patents in the world, and the pharmaceutical manufacturer Zada ​​Pharmaceuticals from Bosnia-Herzegovina on the production and sales of international drugs. Contract; It includes licensing agreements for a portfolio of patents that include an anti-carcinogenic, two antidiabetic, one antiviral, an anti-inflammatory and a pro-somatropic formulation. 24 drug license with this license transfers, which transfers the first biyosötik technology between the two countries, approved within two months, the first 10 units of the product before within three months, Bosnia and Herzegovina, then Turkey, the Benelux countries and will be released throughout Western Europe. In accordance with the signed protocol, the two parties will walk together on production and marketing.

"Turkey's national drug We want to deploy to the whole world"

Making a statement on the subject, Erdal Can Alkoçlar, Chairman of the Board of Mas İlaç Yatırım A.Ş., said, "The areas we prioritize are cancer and diabetes. Other areas we target after the first phase drugs find their place on the shelves will be acute viral and bacterial infections. a subject that you want to turn into significant revenues and time. We were patented before, to institutionalization, we want to support our inventors at all stages up to turn into funding products. Turkey's national drug We want to deploy to the whole world, "he said.

in almost every area of ​​Turkey that it has thousands of manufacturers brain, was to serve all of humanity that emphasizes Alkoçlar to invest this huge source of purpose, until such time himself unable to express or undiscovered said, noting that aims to support the human resource, the resource Turkey and the world He said that he had the potential to change his future.

TBY Holding